Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868608335Aexternal-prioritypatent/GB8608335D0/en
Application filed by Pfizer LtdfiledCriticalPfizer Ltd
Publication of LV5619A3publicationCriticalpatent/LV5619A3/lv
Спосіб одержання бензолсульфонатної солі 3-етіл-5метілового ефіру 2-(2-аміноетоксіметіл)-4-(2-хлорфеніл)-6-метіл-1,4-дігідропірідін-3,5-дікарбонової кислоти
Methyl, isopropyl-4-(2,1,3-benzoxadiazool-4-yl)-2,6-dimethyl-1,4-dihydro pyridine-3,5-dicarboxylaat en farmaceutisch preparaat dat deze verbinding bevat.
Farmaceutiske præparater med en speciel krystalmodifikation af 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarboxylsyre-isopropyl-(2-methoxyethyl)-ester
Fremgangsmaade til fremstilling af den optiske d-isomer af diastereomeren aeaae af 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester
4-(aryl eller heteroaryl)-2-(heteroarylalkoxymethyl)-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere og farmaceutiske praeparater indeholdende disse